Nordhealth AS (OSL:NORDH)
Norway · Delayed Price · Currency is NOK 24.20
-0.20 (-0.82%)
Aug 26, 2026, 4:01 PM CET
Nordhealth AS Ratios and Metrics
Market cap in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,909 | 2,967 | 3,511 | 1,960 | 1,780 | 3,200 | |
Market Cap Growth | -34.06% | -15.48% | 79.08% | 10.11% | -44.37% | - |
Enterprise Value | 1,768 | 2,774 | 3,275 | 1,649 | 1,332 | 2,461 |
Last Close Price | 24.20 | 37.00 | 44.40 | 24.80 | 22.20 | 40.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 44.38 | 150.51 | 52.81 | 52.81 | 94.36 |
PS Ratio | 3.17 | 4.93 | 6.54 | 4.75 | 5.45 | 15.73 |
PB Ratio | 3.07 | 4.07 | 4.05 | 2.11 | 1.71 | 2.79 |
P/TBV Ratio | 18.46 | 19.09 | 15.75 | 8.26 | 5.54 | 4.78 |
P/FCF Ratio | - | - | - | - | - | 145.84 |
P/OCF Ratio | - | 348.66 | 161.51 | - | - | 57.37 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.94 | 4.61 | 6.10 | 4.00 | 4.08 | 12.10 |
EV/EBITDA Ratio | - | - | 90.18 | - | - | - |
EV/FCF Ratio | - | - | - | - | - | 112.14 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / FCF Ratio | - | - | - | - | - | 0.02 |
Net Debt / Equity Ratio | -0.23 | -0.24 | -0.27 | -0.27 | -0.40 | -0.63 |
Net Debt / EBITDA Ratio | 1.19 | 2.55 | -6.35 | 17.77 | 6.56 | 327.11 |
Net Debt / FCF Ratio | 1.71 | 3.36 | 6.19 | 2.03 | 2.99 | -33.16 |
Asset Turnover | 0.71 | 0.66 | 0.52 | 0.36 | 0.26 | 0.29 |
Quick Ratio | 1.50 | 2.08 | 2.87 | 3.05 | 2.74 | 7.64 |
Current Ratio | 1.60 | 2.21 | 2.99 | 3.14 | 2.85 | 7.71 |
Return on Equity (ROE) | -25.82% | -18.76% | -9.81% | -12.27% | -13.38% | -7.92% |
Return on Assets (ROA) | -12.63% | -10.09% | -5.52% | -6.88% | -7.64% | -4.04% |
Return on Invested Capital (ROIC) | -35.20% | -24.73% | -13.48% | -18.97% | -28.96% | -19.79% |
Return on Capital Employed (ROCE) | -27.40% | -20.30% | -10.50% | -13.70% | -14.80% | -3.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -9.43% | -5.06% | -2.57% | -6.37% | -8.44% | -1.48% |
FCF Yield | -4.33% | -1.75% | -1.06% | -6.26% | -7.75% | 0.69% |
Buyback Yield / Dilution | 0.27% | 0.32% | - | - | -0.24% | - |